List of Excipients in API daridorexant
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing daridorexant
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | FERRIC OXIDE RED | 2034-12-02 |
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | FERROSOFERRIC OXIDE | 2034-12-02 |
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | GLYCERIN | 2034-12-02 |
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | HYPROMELLOSE | 2034-12-02 |
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | MAGNESIUM STEARATE | 2034-12-02 |
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | MANNITOL | 2034-12-02 |
| Idorsia Pharmaceuticals Ltd | QUVIVIQ | daridorexant | 80491-7825 | MICROCRYSTALLINE CELLULOSE 101 | 2034-12-02 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Showing 1 to 7 of 7 entries
Detailed excipient profiles for daridorexant
Excipient focus: FERRIC OXIDE RED
daridorexant drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: FERROSOFERRIC OXIDE
daridorexant drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: GLYCERIN
daridorexant drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: HYPROMELLOSE
daridorexant drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: MAGNESIUM STEARATE
daridorexant drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: MANNITOL
daridorexant drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
daridorexant drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
daridorexant drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: POVIDONE K30
daridorexant drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: SILICON DIOXIDE
daridorexant drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: TALC
daridorexant drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: TITANIUM DIOXIDE
daridorexant drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: WATER
daridorexant drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Idorsia Pharmaceuticals Ltd | daridorexant | 80491-7825 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
daridorexant drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
